Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) just unveiled an update.
Concord Healthcare Group Co., Ltd. has announced a financing cooperation with Beijing Daxing Development Finance Leasing Co., Ltd., securing up to RMB20 million for three years at an interest rate of 4.19%. This partnership is expected to expand Concord Healthcare’s financing channels, diversify funding sources, and establish long-term relationships with professional institutions, supporting its future business development.
The most recent analyst rating on (HK:2453) stock is a Sell with a HK$5.50 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. operates in the healthcare industry in China, focusing on providing healthcare services and products. The company aims to enhance its market presence and financial stability through strategic partnerships and diversified funding sources.
Average Trading Volume: 11,030,898
Technical Sentiment Signal: Sell
For an in-depth examination of 2453 stock, go to TipRanks’ Overview page.